Helicobacter hypothesis for idiopathic parkinsonism: before and beyond

Area of Science:

• Microbiology
• Neuroscience
• Immunology

Background:

• Idiopathic parkinsonism (IP) is traditionally viewed as progressive neurodegeneration.
• This perspective challenges the inevitability of neurodegeneration in IP.
• A novel hypothesis proposes microbial insults triggering host responses as a cause.

Purpose of the Study:

• To investigate the role of microbial infections, specifically Helicobacter pylori, in the pathogenesis of idiopathic parkinsonism.
• To explore the potential of eradicating H. pylori infection as a therapeutic strategy for IP.
• To examine the relationship between H. pylori infection markers and disease burden/progression in IP patients.

Main Methods:

• Case studies and placebo-controlled trials of H. pylori eradication.
• Analysis of serum H. pylori antibody profiles and urea breath tests.
• Assessment of clinical symptoms, disease burden, and progression.
• Evaluation of duodenal enterocyte mitochondrial morphology and intestinal transit.

Main Results:

• Eradication of H. pylori infection showed potential in converting "malignant" IP to "benign" and improving bradykinesia/hypokinesia.
• Serum H. pylori antibody profiles correlated with disease burden and progression, acting as a discriminant index.
• Abnormal bowel function, including constipation and diarrhea, was linked to H. pylori infection and potential small intestinal bacterial overgrowth.
• Specific duodenal enterocyte mitochondrial abnormalities were observed in relation to H. pylori infection.

Conclusions:

• Microbial insults, particularly H. pylori, may play a significant role in the development and progression of idiopathic parkinsonism.
• H. pylori eradication may offer a novel therapeutic avenue for managing IP symptoms and slowing disease progression.
• Host inflammatory response and gut dysbiosis, potentially triggered by microbial factors, could influence the evolution of parkinsonian symptoms.